Cargando…
Regular use of aspirin and pancreatic cancer risk
BACKGROUND: Regular use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) has been consistently associated with reduced risk of colorectal cancer and adenoma, and there is some evidence for a protective effect for other types of cancer. As experimental studies reveal a possible rol...
Autores principales: | Menezes, Ravi J, Huber, Kenneth R, Mahoney, Martin C, Moysich, Kirsten B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC126211/ https://www.ncbi.nlm.nih.gov/pubmed/12213184 http://dx.doi.org/10.1186/1471-2458-2-18 |
Ejemplares similares
-
Regular aspirin use and lung cancer risk
por: Moysich, Kirsten B, et al.
Publicado: (2002) -
Headliners: Breast Cancer: Regular Aspirin Use May Decrease Breast Cancer Risk
por: Phelps, Jerry
Publicado: (2004) -
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility
por: Hurwitz, Lauren M., et al.
Publicado: (2023) -
Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations
por: Sheth, Harsh, et al.
Publicado: (2018) -
Aspirin use and pancreatic cancer risk: A systematic review of observational studies
por: Sun, Jinjin, et al.
Publicado: (2019)